Work

Effect of ipilimumab treatment on 18-month survival: Update of patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.9033

Authors: S. O'Day, J. Weber, C. Lebbe, M. Maio, H. Pehamberger, K. Harmankaya, J. Siegel, A. Hoos, R. Humphrey, J. Wolchok

Institutions: University of Vienna, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Bristol-Myers Squibb (United States), Angeles Clinic and Research Institute, Hôpital Saint-Louis, Medical University of Vienna

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2398418149

Cites:

Cited by: 21

Related to: 10